Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OncoGel in Recurrent Glioma
NCT00479765Phase 2Terminated
- Sponsor
- Boston Scientific Corporation
- Start
- Mar 2007
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in glioblastoma multiforme (GBM), sponsored by Boston Scientific Corporation. Started Mar 2007; status: terminated.
02
Drugs
paclitaxel
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00479765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00479765.